| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Testosterone and hormone clinic or telehealth website |
| Population | Men |
| Source | Voy |
| URL | joinvoy.com/blog/hcg-monotherapy-for-men (opens in a new tab) |
Specific Claim Evaluated
hCG acts like luteinizing hormone to stimulate testicular testosterone production and can preserve fertility while raising testosterone, including when combined with testosterone therapy.
Primary Research Supporting or Contradicting the Claim
In a retrospective review of 26 hypogonadal men receiving testosterone with low-dose hCG every other day, semen parameters were maintained, no patient became azoospermic and 9 contributed to a pregnancy (Hsieh et al., 2013).
Corrected Evidence-Based Interpretation
The article is correct. Supporting data for hCG with testosterone come from small retrospective series rather than randomized trials.
Rationale for Grade
The mechanism, onset of effect and fertility claims are consistent with the cited evidence, and the side effects listed are appropriate. The page does not overstate the size or design of the supporting studies for the evaluated claim.
References
- Hsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. PMID
Supporting excerpt: "No patient became azoospermic during concomitant testosterone replacement and human chorionic gonadotropin therapy."